Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers. Academic Article uri icon

Overview

publication date

  • September 4, 2018

Identity

PubMed Central ID

  • PMC6447364

Scopus Document Identifier

  • 85077486491

Digital Object Identifier (DOI)

  • 10.1200/PO.18.00126

PubMed ID

  • 30957057

Additional Document Info

volume

  • 2